Halozyme Therapeutics | HALO - Kapitał Własny I Rezerwy

Cena Akcji
63.83
Dzienna Zmiana
0.77 1.22%
Miesięcznie
-1.24%
Rocznie
6.33%
Q2 Prognozy TE
63.96




Kapitał Własny I Rezerwy Zmiana Data
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
Amarin USD 449.41M 9.87M 2026-03
Amgen USD 8.66B 961M 2025-12
Baxter International USD 6.04B 86M 2026-03
Cara Therapeutics USD 27.87M 5.06M 2025-09
Cytokinetics USD -659.62M 138.5M 2025-12
DBV Technologies USD 168.77M 115.92M 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
Esperion Therapeutics USD -301.96M 149.4M 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Intrexon USD 43.17M 75.33M 2024-06
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
MannKind USD -51.02M 6.47M 2025-12
Minerva Neurosciences USD -140.75M 106.17M 2025-12
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
United Therapeutics USD 7.1B 506M 2025-12
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12